MALVERN, Pa. & STAFFORD, England--(BUSINESS WIRE)--PuriCore (LSE:PURI), the life sciences company focused on the control of infectious pathogens with its novel, safe antimicrobial technology, announces that it has arranged a new borrowing facility totaling $20 million with Brown Brothers Harriman & Co. The new facility is a demand line of credit at the London Interbank Offered Rate (LIBOR) plus 1.75%. Approximately $4.25 million of this facility will be used immediately to refinance existing debt, while the remainder of the line is available to fund purchases of new equipment and for general working capital.
